ASEAN & US corporate wellness market is anticipated to reach valuation of US$ 30.82 Bn in 2030 from US$ 18.29 Bn in 2021. The market is expected to register healthy growth at a CAGR of 5.88 % during the forecast period 2022–2030.
Japan pet cancer therapeutics market was valued at US$ 15.3 Million in 2024 and is projected to reach a valuation of US$ 29.1 Million by 2033 at a CAGR of 7.34% during the forecast period 2025-2033.
Global dermatology drugs market was valued at US$ 19.71 billion in 2023 and is estimated to reach a valuation of US$ 50.42 billion by 2032 at a CAGR of 11.0% during the forecast period 2024-2032.
Asia Pacific Dermal Fillers Treatment Market is estimated to witness a rise in revenue from US$ 810.3 Million in 2021 to US$ 1,650.3 Million by 2030. The market is registering a CAGR of 8.9% during the forecast period 2022-2030
Global Osimertinib Drugs Market is estimated to witness a rise in revenue from US$ 4,828.6 Mn in 2021 to US$ 11,829.8 Mn by 2027. The market is registering a CAGR of 16.1% during the forecast period 2022-2027
The global over-the-counter (OTC) drugs market is expected to experience significant growth, with revenue projected to rise from US$ 1,29,963.03 Mn in 2022 to US$ 2,38,453.92 Mn by 2031, registering a CAGR of 7.0% during the forecast period.
Cancer pain diagnostics market was valued at US$ 7.49 billion in 2024 and is projected to hit the market valuation of US$ 11.23 billion by 2033 at a CAGR of 4.6% during the forecast period 2025–2033.
Japan bioanalytical testing services market is projected to make a forward leap in its revenue from US$ Mn 75.6 million in 2023 to US$ 203.0 Mn by 2032. The market is registering a CAGR of 11.6% over the forecast period 2024-2032.